JAS Worldwide is pleased to announce the appointment of David Bang as Executive Vice-President, Global Pharma & Healthcare.  An innovative thought leader with more than 20 years of experience across logistics, supply chain, healthcare, and life sciences industries, Bang has held various leadership positions throughout his career.  In 2005, he co-founded LifeConEx, a joint venture between DHL and Lufthansa Airlines for bio-pharma international logistics. He became the CEO of the company in 2006, substantially expanding the network to more than 100 stations in 65 countries.  Under Bang's leadership, the company became a globally recognized premier provider of end-to-end temperature-sensitive logistics management solutions with more than a half billion-dollar annual sales serving the pharma and healthcare industry.  

Most recently, Bang was Global VP Strategic Development for Hellmann where he spearheaded the global development of their healthcare network. He has also served as a Member of the Board of Rx-360, a patient safety and product integrity advocacy group for two years, and in 2019 was named as a Member of the Board at MaxQ Research, a leader in revolutionary shipping systems for sensitive biologics.

‍

‍

‍